The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. CRISPR Therapeutics AG’s current trading price is -31.40% away from its 52-week high, while its distance from the 52-week low is 45.42%. The stock’s price range for this period has been between $30.04 and $63.68 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.16 million for the day, a number notably higher than the average daily volume of 2.15 million over the last three months.
CRISPR Therapeutics AG saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $63.68 on 07/16/24, while the lowest price for the same duration was marked at $30.04 on 04/07/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
CRISPR Therapeutics AG (CRSP) has experienced a quarterly rise of 6.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.77B and boasts a workforce of 393 employees.
Analyzing Trading Volume and Moving Average Trends
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CRSP stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.
CRSP Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 10.99% this year. Over the last six months, there has been a stronger performance of -3.78%. The price of CRSP fallen by 12.68% during the last 30 days period. For the last 5-days stocks have improved 1.74%.
